
Daclatasvir (60mg)
Active composition
Daclatasvir inhibits the NS5A protein of the hepatitis C virus, disrupting the viral replication process and reducing viral load.
Medical applications
Mydekla 60 Tablet contains Daclatasvir as its active ingredient, providing a vital component in the treatment of chronic hepatitis C virus (HCV) infection. This medication is part of a combination therapy, primarily indicated for genotype 1, 4, 5, and 6 HCV infections in adults. Mydekkla works by inhibiting the HCV NS5A protein, thereby inhibiting viral replication. It is crucial to follow a prescribed dosage regimen and complete the full course of treatment for optimal therapeutic effect. Consult your healthcare provider for proper dosage and potential drug interactions, as Mydekla may not be suitable for all individuals. Regular monitoring of liver function tests is essential during treatment to ensure safe and effective use.
How to use Mydekla Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Mydekla 60 Tablet may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is not known whether it is safe to consume alcohol with Mydekla 60 Tablet. Please consult your doctor.
High Risk
Mydekla 60 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
It is not known whether Mydekla 60 Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Exercise Caution
Mydekla 60 Tablet is safe to use in patients with liver disease. No dose adjustment of Mydekla 60 Tablet is recommended.
Regular Checkup
Mydekla 60 Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Consult Doctor
Mydekla 60 Tablet is safe to use in patients with kidney disease. No dose adjustment of Mydekla 60 Tablet is recommended.
Regular Checkup
0 reviews for Mydekla 60 Tablet

Daclatasvir (60mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Daclatasvir inhibits the NS5A protein of the hepatitis C virus, disrupting the viral replication process and reducing viral load.
Medical applications
Mydekla 60 Tablet contains Daclatasvir as its active ingredient, providing a vital component in the treatment of chronic hepatitis C virus (HCV) infection. This medication is part of a combination therapy, primarily indicated for genotype 1, 4, 5, and 6 HCV infections in adults. Mydekkla works by inhibiting the HCV NS5A protein, thereby inhibiting viral replication. It is crucial to follow a prescribed dosage regimen and complete the full course of treatment for optimal therapeutic effect. Consult your healthcare provider for proper dosage and potential drug interactions, as Mydekla may not be suitable for all individuals. Regular monitoring of liver function tests is essential during treatment to ensure safe and effective use.
How to use Mydekla Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Mydekla 60 Tablet may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is not known whether it is safe to consume alcohol with Mydekla 60 Tablet. Please consult your doctor.
High Risk
Mydekla 60 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
It is not known whether Mydekla 60 Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Exercise Caution
Mydekla 60 Tablet is safe to use in patients with liver disease. No dose adjustment of Mydekla 60 Tablet is recommended.
Regular Checkup
Mydekla 60 Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Consult Doctor
Mydekla 60 Tablet is safe to use in patients with kidney disease. No dose adjustment of Mydekla 60 Tablet is recommended.
Regular Checkup
0 reviews for Mydekla 60 Tablet















